GLP1R and type 2 diabetes mellitus: In any case, to overcome this short-coming, we additionally, performed a paired Wilcoxon test on a cohort of thirty-two T2DM patients from the same PROVALID study, receiving only the anti-hypertensive drugs and no GLP-1R agonist drugs, that were matched to the GLP-1R agonist treated cohort by age, sex, BMI, SBP, DBP and eGFR.